Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report) traded down 3% during mid-day trading on Tuesday . The company traded as low as $2.0750 and last traded at $2.0750. 18,057 shares were traded during trading, an increase of 120% from the average session volume of 8,214 shares. The stock had previously closed at $2.14.
Mayne Pharma Group Price Performance
The stock’s fifty day moving average is $2.41 and its two-hundred day moving average is $3.04.
About Mayne Pharma Group
Mayne Pharma Group (OTCMKTS:MAYNF) is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of prescription products. The company’s portfolio spans oral, transdermal and topical dosage forms, with a particular emphasis on women’s health, dermatology, pain management and other niche therapeutic areas. Through both branded and generic offerings, Mayne Pharma seeks to address unmet patient needs and provide cost-effective alternatives to established treatments.
In its development operations, Mayne Pharma leverages a combination of in-house research and external partnerships to advance product candidates through regulatory review.
Recommended Stories
- Five stocks we like better than Mayne Pharma Group
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
